A strategic tender category — WHO Prequalification here unlocks Global Fund and Stop TB Partnership procurement.
HS Code: 3004.90Markets: Africa, SE Asia, Global Fund tendersMolecules Tracked: 38
What This Class Covers
First-line and multidrug-resistant TB therapy, from the standard HRZE fixed-dose combination to newer agents like bedaquiline and delamanid, plus leprosy MDT blister packs. This is a tender-driven, high-volume, predictable-reorder category rather than a spot-market one — WHO Prequalification is effectively the entry ticket to donor-funded procurement at scale.
Showing 38 of 38 molecules tracked in this class. Contact us for a specific molecule not listed here.
Prescription Breakdown
OTC
0
Prescription (Rx)
38
Restricted / Controlled
0
Export and prescription status vary by molecule, strength, pack size and destination. Verify current requirements with the relevant authority before shipment.